Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior
- PMID: 25755036
- PMCID: PMC4369602
- DOI: 10.1370/afm.1737
Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior
Abstract
Purpose: There is limited trial evidence concerning the long-term effects of screening for type 2 diabetes on population morbidity. We examined the effect of a population-based diabetes screening program on cardiovascular morbidity, self-rated health, and health-related behaviors.
Methods: We conducted a pragmatic, parallel-group, cluster-randomized controlled trial of diabetes screening (the ADDITION-Cambridge study) including 18,875 individuals aged 40 to 69 years at high risk of diabetes in 32 general practices in eastern England (27 practices randomly allocated to screening, 5 to no-screening for control). Of those eligible for screening, 466 (2.9%) were diagnosed with diabetes. Seven years after randomization, a random sample of patients was sent a postal questionnaire: 15% from the screening group (including diabetes screening visit attenders and non-attenders) and 40% from the no-screening control group. Self-reported cardiovascular morbidity, self-rated health (using the SF-8 Health Survey and EQ-5D instrument), and health behaviors were compared between trial groups using an intention-to-screen analysis.
Results: Of the 3,286 questionnaires mailed out, 1,995 (61%) were returned, with 1,945 included in the analysis (screening: 1,373; control: 572). At 7 years, there were no significant differences between the screening and control groups in the proportion of participants reporting heart attack or stroke (OR = 0.90, 95% CI, 0.71-1.15); SF-8 physical health summary score as an indicator of self-rated health status (β -0.33, 95% CI, -1.80 to 1.14); EQ-5D visual analogue score (β: 0.80, 95% CI, -1.28 to 2.87); total physical activity (β 0.50, 95% CI, -4.08 to 5.07); current smoking (OR 0.97, 95% CI, 0.72 to 1.32); and alcohol consumption (β 0.14, 95% CI, -1.07 to 1.35).
Conclusions: Invitation to screening for type 2 diabetes appears to have limited impact on population levels of cardiovascular morbidity, self-rated health status, and health behavior after 7 years.
Keywords: ADDITION-Cambridge; cardiovascular morbidity; diabetes; health behavior; screening; self-rated health.
© 2015 Annals of Family Medicine, Inc.
Figures
Comment in
-
Long term impact of screening for type 2 diabetes mellitus - a commentary on new evidence.Evid Based Med. 2015 Aug;20(4):135. doi: 10.1136/ebmed-2015-110208. Epub 2015 Jun 30. Evid Based Med. 2015. PMID: 26126760 No abstract available.
References
-
- Vascular Programme, Department of Health. Putting Prevention First. Vascular checks: Risk assessment and management. London, England: Department of Health; 2008.
-
- American Diabetes Association. Screening for type 2 diabetes. Diabetes Care. 2004;27(Suppl 1):S11–S14. - PubMed
-
- Bewley S. The NHS breast screening programme needs independent review. BMJ. 2011;343(d6843):d6894. - PubMed
-
- Bankhead CR, Brett J, Bukach C, et al. The impact of screening on future health-promoting behaviours and health beliefs: a systematic review. Health Technol Assess. 2003;7(42):1–92. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical